WHO ICTRP trial
Clinical study on the efficacy, safety and immunogenicity of therapeutic human…
ChiCTR2500108397 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500108397 |
|---|---|
| Public title | Clinical study on the efficacy, safety and immunogenicity of therapeutic human papillomavirus mRNA vaccine (RCZL11) in patients with persistent HPV16 infection |
| Scientific title | Clinical study on the efficacy, safety and immunogenicity of therapeutic human papillomavirus mRNA vaccine (RCZL11) in patients with persistent HPV16 infection |
| Primary sponsor | Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Human papillomavirus infection and cervical intraepithelial neoplasia |
| Interventions | MAD Experiment - Experimental Group:Receive three doses of therapeutic vaccine injections;MAD Experiment - Control Group:None;SAD experiment group:Receive one dose of therapeutic vaccine injection |
| Registration date | Aug 29, 2025 |
| Target size | MAD Experiment - Experimental Group:6;MAD Experiment - Control Group:3;SAD… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: